University of California-San Francisco · PharmacologySavic Tuberculosis Lab
Radojka Savic · San Francisco, California
Research Focus
Dr. Radojka Savic's lab at UCSF focuses on improving tuberculosis (TB) treatment by developing new drug regimens and diagnostics. The lab aims to enhance the accuracy of TB diagnosis through innovative blood tests that measure cell-free RNA, and to optimize treatment strategies using advanced modeling and animal studies. By collaborating with a multidisciplinary team, they seek to tackle the pressing global health challenge of TB, aiming for shorter and more effective treatment options.
tuberculosisdrug regimensRNA biomarkersclinical trialsanimal modelspreclinical researchbiomarkerstreatment optimizationsystematic evaluations
Research Aims
5AIM 01Establish a comprehensive consortium for TB drug regimen research.
AIM 02Optimize preclinical and clinical trial processes for TB treatments.
AIM 03Develop and validate plasma cell-free RNA as a TB biomarker.
AIM 04Create predictive models to enhance treatment regimen success rates.
AIM 05Evaluate new drug combinations for multidrug-resistant TB.
Skills the Lab Values
cell culturemouse modelsRNA sequencingPCRdata modelingbiostatisticspharmacodynamicstranslational researchclinical trial design
Output against the department
Publications134bottom 38% of dept.287th of 462
this lab
most publishedleast published
Citations5.4kbottom 40% of dept.279th of 462
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.